Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Heat treatment increases hair loss in certain mice.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

The guideline provides recommendations for managing alopecia areata effectively.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Altered hypothalamic activity may contribute to stress in alopecia areata patients.

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Alopecia areata is linked to PTSD, alcohol use, anxiety, and depression.